Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Jul;14(7):598-605.
doi: 10.3779/j.issn.1009-3419.2011.07.07.

[The status and prospects of treatment protocols for elderly patients with non-small cell lung cancer]

[Article in Chinese]
Jianping Zhou  1 , Beili Gao
Affiliations
Review

[The status and prospects of treatment protocols for elderly patients with non-small cell lung cancer]

[Article in Chinese]
Jianping Zhou et al. Zhongguo Fei Ai Za Zhi. 2011 Jul.

Abstract
in English, Chinese

In recent years, the incidence and mortality of advanced lung cancer in elderly patients have been increasing. However, the general acceptance of treatment more than best supportive care in the elderly patients is not optimistic, because the social-economic, family and other factors besides health care were involved in the treatment strategy. In this review, we summarize the current status and prospect of treatment protocols for elderly patients with non-small cell lung cancer.

近年来，老年晚期肺癌发病率和死亡率呈明显上升趋势，但老年患者总体接受积极治疗的人数却明显少于非老年患者，同时因受到社会、经济、家庭等医疗以外诸多因素的影响，老年晚期肺癌患者治疗现状不容乐观。现就当前国内外老年非小细胞肺癌患者的治疗现状和趋势作一综述。

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Ling Yang, Maxwell P, Jacques F, et al. Estimates of cancer incidence in China for 2000 and projections for 2005. Biomarkers Prev. 2005;14(1):243–250. - PubMed
    1. Owonikoko TK, Ragin CC, Belani CP, et al. Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database. J Clin Oncol. 2007;25(35):5570–5577. doi: 10.1200/JCO.2007.12.5435. - DOI - PubMed
    1. Koumarianou A, Fountzilas G, Kosmidis P, et al. Non small cell lung cancer in the elderly: clinico-pathologic, management and outcome characteristics in comparison to younger patients. J Chemother. 2009;21(5):573–583. doi: 10.1179/joc.2009.21.5.573. - DOI - PubMed
    1. Altundag O, Stewart DJ, Fossella FV, et al. Many patients 80 years and older with advanced non-small cell lung cancer (NSCLC) can tolerate chemotherapy. J Torac Oncol. 2007;2(2):141–146. doi: 10.1097/JTO.0b013e3180311792. - DOI - PubMed
    1. Hainsworth JD, Spigel DR, Farley C, et al. Weekly docetaxel versus docetaxel/gemcitabine in the treatment of elderly or poor performance status patients with advanced nonsmall cell lung cancer: a randomized phase 3 trial of the Minnie Pearl Cancer Research Network. Cancer. 2007;110(9):2027–2034. doi: 10.1002/(ISSN)1097-0142. - DOI - PubMed

Substances